BridgeMD
New treatment option for Juvenile Idiopathic Arthritis
Official title Health and Exercise Response in Children With Chronic and Auto-immune Pathologies
ClinicalTrials.gov ID: NCT03913962
What this study is testing
- What it's testing
- The aim of the present project is to assess the effects of the chronic diseases and their associated treatments chronic paediatric diseases (CPD), to further understand their impact on physical fitness for public health perspectives. This is an innovative approach in the treatment of chronic paediatric diseases .
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 6 to 18. Healthy volunteers may be eligible.
You may be able to join if
- for patients:
- Aged between 6 and 18-year-old
- Male or female
- Presenting a chronic pathology / having a treatment which is known to alter muscle mass and function, metabolism and body composition
- Included in the active list of the hospital centre of Clermont-Ferrand
You likely can't join if
- for patients:
- Treatment by systemic corticoids (\>1 week in the 30 days before test)
- Contraindication to sport practice
- Active infection for control:
- Contraindication to sport practice
- Chronic pathology susceptible to alter muscle mass and function, metabolism and body composition
See the full eligibility criteria
- for patients:
- Aged between 6 and 18-year-old
- Male or female
- Presenting a chronic pathology / having a treatment which is known to alter muscle mass and function, metabolism and body composition
- Included in the active list of the hospital centre of Clermont-Ferrand
- Free and informed consent of the holders of parental authority and the patient
- Affiliated with the social security system for control:
- Aged between 6 and 18-year-old
- Male or female
- Free and informed consent of the holders of parental authority and the patient
- Affiliated with the social security system
- for patients:
- Treatment by systemic corticoids (\>1 week in the 30 days before test)
- Contraindication to sport practice
- Active infection for control:
- Contraindication to sport practice
- Chronic pathology susceptible to alter muscle mass and function, metabolism and body composition
- Treatment susceptible to alter metabolism
- Active infection
The study team makes the final eligibility decision.
Where it's taking place
- Clermont-Ferrand, France
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 6 years to 18 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Clermont-Ferrand, France. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.